| 注册
首页|期刊导航|天然产物研究与开发|血根碱通过下调TGF-β1/Smad通路抑制紫杉醇耐药卵巢癌细胞生长

血根碱通过下调TGF-β1/Smad通路抑制紫杉醇耐药卵巢癌细胞生长

王妍妍 张琴 冷天艳 杨丽华

天然产物研究与开发2017,Vol.29Issue(7):1127-1131,5.
天然产物研究与开发2017,Vol.29Issue(7):1127-1131,5.DOI:10.16333/j.1001-6880.2017.7.008

血根碱通过下调TGF-β1/Smad通路抑制紫杉醇耐药卵巢癌细胞生长

Sanguinarine Inhibits the Growth of Paclitaxel Resistant Ovarian Cells by Down-Regulating the TGF-β1/Smad Pathway

王妍妍 1张琴 1冷天艳 1杨丽华1

作者信息

  • 1. 昆明医科大学第二附属医院妇科,昆明650301
  • 折叠

摘要

Abstract

Paclitaxel resistant ovarian cancer A2780/Taxol cells were divided into control group and sanguinarine group.The cells in control group were treated without sanguinarine.The cells in sanguinarine group were treated with different concentrations of sanguinafine (0.67 μmol/L,1.0 μmol/L,2.0 μmol/L).The proliferation,apoptosis,cycle and the expression of Bax,TGF-beta 1,Smad3 were determined by MTT,clone formation,flow cytometry and Western blot assays.It was found that the proliferation of A2780/Taxol cells were significantly inhibited by 2.0 μmol/L of sanguinarine.Compared to the control group,the expressions of Bax protein increased and TGF-β1,Smad3 protein decreased (P< 0.05).Hence,it was concluded that sanguinarine can effectively inhibit the growth of A2780/Taxol cells by downregulating the TGF-β1/Smad3 pathway and inducing cell apoptosis.

关键词

血根碱/卵巢癌/紫杉醇耐药/TGF-β1/Smad

Key words

sanguinarine/ovarian cancer/paclitaxel resistance/TGF-β1/Smad

分类

医药卫生

引用本文复制引用

王妍妍,张琴,冷天艳,杨丽华..血根碱通过下调TGF-β1/Smad通路抑制紫杉醇耐药卵巢癌细胞生长[J].天然产物研究与开发,2017,29(7):1127-1131,5.

基金项目

云南省卫生和计划生育委员会医学学科带头人培养项目(D-201633) (D-201633)

国家自然科学基金地区(81360336) (81360336)

云南省科技厅-昆明医科大学应用基础研究联合专项资金项目 ()

天然产物研究与开发

OA北大核心CSCDCSTPCD

1001-6880

访问量0
|
下载量0
段落导航相关论文